Viewing Study NCT05745350

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 5:05 PM

Ignite Modification Date: 2026-01-22 @ 2:41 AM

Study NCT ID: NCT05745350

Status: RECRUITING

Last Update Posted: 2025-02-11

First Post: 2023-02-05

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC

Sponsor: Xiaorong Dong

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module